The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results